Global Cancer Biomarkers - Expected to Reach Around $17 Billion By 2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.

The global cancer biomarkers market is anticipated to reach around $17 billion by 2022, with an estimated CAGR of 12.6% from 2016 to 2022.

The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in -omics technologies, increased demand for personalized medicines especially in cancer therapies, rising number of clinical trials in developed as well as developing countries, favorable government research funding for cancer research, and rising R&D expenditures by pharmaceutical companies. However, poorly suited regulatory and reimbursement systems of biomarker tests and huge capital investments for biomarker discovery and development are restricting the growth of this market.

In 2015, North America accounted for the largest share in the global cancer biomarkers market, followed by European region, Asia-Pacific, and RoW. This huge growth in the North American market is majorly due to cumulative government support for discovery and development of biomarkers, increasing demand for personalized medicine, early adoption of various technologically advanced omics for the biomarker discovery, and the growing application of biomarkers for drug discovery and development by pharmaceutical companies in the region.

However, the Asia-Pacific market is expected to witness high growth in the forecast period, owing to rising prevalence of cancer, increasing government support, expansion by major market players, and increasing use of biomarker tests for diagnosis in this region.

Companies Mentioned:

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Agendia Bv
  • Agilent Technologies, Inc.
  • Ambriliabiopharma
  • Astellas Pharma Us Inc.
  • Aureon Laboratories Inc.
  • Beckman Coulter
  • Becton Dickinson And Company
  • Biomoda Inc.
  • Clarient, Inc.
  • Diadexus Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Roche Diagnostics Ltd.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Geographical Analysis

6. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/8kdlrw/global_cancer

Related Reports:

Related Topics: Biomarkers

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716